MET

MetLife is a company that the financial press often treats as a bellwether for the insurance industry, yet the structural reality is more interesting than the label suggests. With roughly $70 billion in annual revenue, operations in over 40 countries, and a sprawling portfolio that spans group benefits, retirement solutions, individual life insurance, and asset management, MetLife sits at the intersection of nearly every demographic and macroeconomic force that shapes modern financial services. Aging populations in developed markets, growing middle classes in emerging economies, persistent low and then rapidly rising interest rates, the digitization of employee benefits: all of these currents pass through MetLife's business lines in one form or another.

But the central question is not whether MetLife is big. It is. The question is whether MetLife's structural position in insurance markets confers the kind of irreplaceable, ecosystem-defining power that separates a true franchise from a well-run conglomerate. In life and health insurance, the answer is rarely simple. Unlike technology platforms where winner-take-all dynamics concentrate power, insurance operates on a logic of diversification, actuarial discipline, and regulatory capital. Scale helps, but scale in insurance is not the same as lock-in in software.

Here is the L17X observation that reframes MetLife's position: MetLife's deepest competitive advantage is not in any product it sells to individuals, but in the structural stickiness of its group benefits relationships, where the switching cost is borne not by MetLife's customer (the employer) but by the employer's employees, who never chose MetLife in the first place and cannot easily leave. This creates an unusual form of embedded dependency where the end user has no agency in the relationship, and the institutional buyer has limited incentive to disrupt it. The result is a retention dynamic that mimics platform lock-in without requiring a platform.

MetLife's story in the mid-2020s is one of deliberate portfolio reshaping: the sale of legacy businesses, the pivot toward higher-margin segments, and a sustained capital return program that has compressed the share count materially over the past decade. The company has exited direct-to-consumer retail life insurance in significant ways, shed its variable annuity liabilities through reinsurance transactions, and leaned into group benefits and international growth. This analysis examines whether those moves have produced a genuinely differentiated structural position or simply a cleaner version of an inherently commoditized business.